Using urinary neutrophile gelatinase-associated lipocalin for prognosticate renal dysfunction in children with familial Mediterranean fever the study design: a pilot study
Open Access
- 1 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Advances in Rheumatology
- Vol. 61 (1), 1-7
- https://doi.org/10.1186/s42358-021-00178-4
Abstract
The most important finding that affects the prognosis in Familial Mediterranean Fever is renal amyloidosis. The aim of the present study was to analyze neutrophil gelatinase-associated lipocalin levels in the urine, and to investigate whether it may be used as an early marker for renal involvement. Forty attack-free children followed by diagnosis of Familial Mediterranean Fever with age range of 5 and 18 years, and 38 healthy children with similar ages and genders were enrolled into the study. Hemogram, sedimentation, C-reactive protein, urine analysis, creatinine in the spot urine, microalbumin and urinary neutrophil gelatinase-associated lipocalin levels were analyzed and evaluated statistically in the patients and controls. There was not any statistically significant difference between the patient and control groups for age, gender, height and body weight. Although there was not any clinical sign of attack in the patient group, sedimentation, C-reactive protein and fibrinogen levels were significantly higher than the control group (p = 0.002, p = 0.023, and p = 0.006, respectively). Similarly, urinary neutrophil gelatinase-associated lipocalin level and urinary creatinine ratio were significantly higher in the patient group (p = 0.0001, p = 0.011, respectively). We found a positive correlation between uNGAL level and uNGAL/uCr ratio and number of attacks per year in FMF patients (r = 0.743, p = 0.001 and r = 0.516, p = 0.001; respectively). Detection of significantly higher levels of urinary neutrophil gelatinase-associated lipocalin level and urinary neutrophil gelatinase-associated lipocalin level to creatinine ratio were suggested as urinary neutrophil gelatinase-associated lipocalin level as a non-invasive marker for renal involvement better than microalbumin.Keywords
This publication has 40 references indexed in Scilit:
- Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI DiagnosisClinical Journal of the American Society of Nephrology, 2011
- Biomarkers for the early detection of acute kidney injuryCurrent Opinion in Pediatrics, 2011
- The Origin of Multiple Molecular Forms in Urine of HNL/NGALClinical Journal of the American Society of Nephrology, 2010
- Familial mediterranean fever with a single MEFV mutation: Where is the second hit?Arthritis & Rheumatism, 2009
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Neutrophil gelatinase‐associated lipocalin (NGAL): A new marker of kidney diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2008
- Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damageKidney International, 2007
- Country as the primary risk factor for renal amyloidosis in familial mediterranean feverArthritis & Rheumatism, 2007
- Phenotype–genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosisEuropean Journal of Human Genetics, 1999
- Enhanced neutrophil chemiluminescence in familial mediterranean feverJournal of Clinical Immunology, 1988